Exploring the Backbone of Enkephalins To Adjust Their Pharmacological Profile for the δ-Opioid Receptor

被引:19
|
作者
Proteau-Gagne, Arnaud [1 ]
Bournival, Veronique [2 ]
Rochon, Kristina [2 ]
Dory, Yves L. [1 ]
Gendron, Louis [2 ]
机构
[1] Univ Sherbrooke, Dept Chim, Lab Synth Supramol, Sherbrooke, PQ J1H 5N4, Canada
[2] Univ Sherbrooke, Inst Pharmacol, Dept Physiol & Biophys, Sherbrooke, PQ J1H 5N4, Canada
来源
ACS CHEMICAL NEUROSCIENCE | 2010年 / 1卷 / 11期
基金
加拿大自然科学与工程研究理事会;
关键词
Enkephalin; delta-opioid receptor; trans-olefin; E-alkene; dipeptide isostere; amide bond; SUBSTANCE-P ENDOPEPTIDASE; ACTIVATED PROTEIN-KINASE; BLOOD-BRAIN-BARRIER; LEUCINE-ENKEPHALIN; DIPEPTIDE ISOSTERES; NG108-15; CELLS; NEUROPATHIC PAIN; DRUG EFFICACY; PEPTIDE-BOND; AGONIST;
D O I
10.1021/cn1000759
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of each of the four amide bonds in Leu(5)-enkephalin was investigated by systematically and sequentially replacing each with its corresponding trans-alkene. Six Leu(5)-enkephalin analogs based on six dipeptide surrogates and two Met(5)-enkephalin analogs were synthesized and thoroughly tested using a delta-opioid receptor internalization assay, an ERK1/2 activation assay, and a competition binding assay to evaluate their biological properties. We observed that an E-alkene can efficiently replace the first amide bond of Leu(5)- and Met(5)-enkephalin without significantly affecting biological activity. By contrast, the second amide bond was found to be highly sensitive to the same modification, suggesting that it is involved in biologically essential intra- or intermolecular interactions. Finally, we observed that the affinity and activity of analogs containing an E-alkene at either the third or fourth position were partially reduced, indicating that these amide bonds are less important for these intra- or intermolecular interactions. Overall, our study demonstrates that the systematic and sequential replacement of amide bonds by E-alkene represents an efficient way to explore peptide backbones.
引用
收藏
页码:757 / 769
页数:13
相关论文
共 45 条
  • [31] Determining Pharmacological Selectivity of the Kappa Opioid Receptor Antagonist LY2456302 Using Pupillometry as a Translational Biomarker in Rat and Human
    Rorick-Kehn, Linda M.
    Witcher, Jennifer W.
    Lowe, Stephen L.
    Gonzales, Celedon R.
    Weller, Mary Ann
    Bell, Robert L.
    Hart, John C.
    Need, Anne B.
    McKinzie, Jamie H.
    Statnick, Michael A.
    Suico, Jeffrey G.
    McKinzie, David L.
    Tauscher-Wisniewski, Sitra
    Mitch, Charles H.
    Stoltz, Randall R.
    Wong, Conrad J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2015, 18 (02) : 1 - 11
  • [32] The pro-nociceptive effects of remifentanil or surgical injury in mice are associated with a decrease in delta-opioid receptor mRNA levels: Prevention of the nociceptive response by on-site delivery of enkephalins
    Cabanero, David
    Celerier, Evelyne
    Garcia-Nogales, Paula
    Mata, Marina
    Roques, Bernard P.
    Maldonado, Rafael
    Puig, Margarita M.
    PAIN, 2009, 141 (1-2) : 88 - 96
  • [33] In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel μ opioid analgesic with reduced propensity to alter motor function
    Spetea, Mariana
    Bohotin, Catalina R.
    Asim, Muhammad F.
    Stuebegger, Kurt
    Schmidhammer, Helmut
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 41 (01) : 125 - 135
  • [34] Effect of Perioperative Opioids on Cancer-Relevant Circulating Parameters: Mu Opioid Receptor and Toll-Like Receptor 4 Activation Potential, and Proteolytic Profile
    Xie, Nan
    Matigian, Nicholas
    Vithanage, Tharindu
    Gregory, Kye
    Nassar, Zeyad D.
    Cabot, Peter J.
    Shaw, Paul N.
    Kirkpatrick, Carl M. J.
    Kim-Anh Le Cao
    Sturgess, David
    Parat, Marie-Odile
    CLINICAL CANCER RESEARCH, 2018, 24 (10) : 2319 - 2327
  • [35] Specific Pharmacological Profile of A2A Adenosine Receptor Predicts Reduced Fractional Flow Reserve in Patients With Suspected Coronary Artery Disease
    Paganelli, Franck
    Resseguier, Noemie
    Marlinge, Marion
    Laine, Marc
    Malergue, Fabrice
    Kipson, Nathalie
    Armangau, Pauline
    Pezzoli, Nicolas
    Kerbaul, Francois
    Bonello, Laurent
    Mottola, Giovanna
    Fenouillet, Emmanuel
    Guieu, Regis
    Ruf, Jean
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [36] Melanocortin receptor accessory protein 2 (MRAP2) interplays with the zebrafish melanocortin 1 receptor (MC1R) but has no effect on its pharmacological profile
    Cortes, Raul
    Josep Agulleiro, Maria
    Navarro, Sandra
    Guillot, Raul
    Sanchez, Elisa
    Miguel Cerda-Reverter, Jose
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2014, 201 : 30 - 36
  • [37] Synthesis of novel twin drug consisting of 8-oxaendoethanotetrahydromorphides with a 1,4-dioxane spacer and its pharmacological activities: μ, κ, and putative ε opioid receptor antagonists
    Fujii, Hideaki
    Watanabe, Akio
    Nemoto, Toru
    Narita, Minoru
    Miyoshi, Kan
    Nakamura, Atsushi
    Suzuki, Tsutomu
    Nagase, Hiroshi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (02) : 438 - 441
  • [38] Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids
    Vidal-Torres, Alba
    Fernandez-Pastor, Begona
    Garcia, Monica
    Ayet, Eva
    Cabot, Anna
    Burgueno, Javier
    Monroy, Xavier
    Aubel, Bertrand
    Codony, Xavier
    Romero, Luz
    Pascual, Rosalia
    Serafini, Maria Teresa
    Encina, Gregorio
    Almansa, Carmen
    Zamanillo, Daniel
    Merlos, Manuel
    Vela, Jose Miguel
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (01) : 82 - 99
  • [39] Fluorescence Correlation Spectroscopy in Drug Discovery: Study of Alexa532-Endothelin 1 Binding to the Endothelin ETA Receptor to Describe the Pharmacological Profile of Natural Products
    Caballero-George, Catherina
    Sorkalla, Thomas
    Jakobs, Daniel
    Bolanos, Jessica
    Raja, Huzefa
    Shearer, Carol
    Bermingham, Eldredge
    Haeberlein, Hanns
    SCIENTIFIC WORLD JOURNAL, 2012,
  • [40] Pharmacological Profile of NCP-322, a Novel G Protein-Coupled Receptor 119 Agonist, as an Orally Active Therapeutic Agent for Type 2 Diabetes Mellitus
    Nakamura, Hideki
    Endo, Tsuyoshi
    Tsuda, Makoto
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2025, 48 (01) : 65 - 74